No Data
No Data
Kangmei Pharmaceutical: Kangmei Pharmaceutical Third Quarter Report 2024
Kangmei Pharmaceutical Report for the Third Quarter of 2024
Express News | The classification list D of insurance representatives is enabled. The first batch of 16 individuals have had their business temporarily suspended and their insurance agency information disclosed.
Express News | The Ministry of Finance has named Luckin Coffee and Evergrande: the cost of financial fraud is too low.
Summary of Kangmei Pharmaceutical's 2024 semi-annual report
Kangmei Pharmaceutical's 2024 interim report
No Data
No Data